{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:45:03Z","timestamp":1781646303983,"version":"3.54.5"},"publisher-location":"Cham","reference-count":120,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031261626","type":"print"},{"value":"9783031261633","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-26163-3_9","type":"book-chapter","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:03:29Z","timestamp":1682323409000},"page":"163-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Appraisal of the Neuroprotective Effect of Dexmedetomidine: A Meta-Analysis"],"prefix":"10.1007","author":[{"given":"Sebastian","family":"Gatica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristobal","family":"Aravena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Aravena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Echeverr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Santibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Stehberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"6","key":"9_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11940-012-0201-x","volume":"14","author":"SS Song","year":"2012","unstructured":"Song SS, Lyden PD (2012) Overview of Therapeutic Hypothermia. Curr Treat Option Ne 14(6):541\u2013548","journal-title":"Curr Treat Option Ne"},{"key":"9_CR2","unstructured":"Black J, Furney S, Graf H, Nolte A (2009) Philosophical foundations of health education. In: Black J (ed)"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3389\/fphys.2018.01487","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhou Z, Min W (2018) Mitochondria, oxidative stress and innate immunity. Front Physiol 9:1487","journal-title":"Front Physiol"},{"issue":"5","key":"9_CR4","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1007\/s12035-018-1277-4","volume":"56","author":"T Yagami","year":"2019","unstructured":"Yagami T, Yamamoto Y, Koma H (2019) Pathophysiological roles of intracellular proteases in neuronal development and neurological diseases. Mol Neurobiol 56(5):3090\u20133112","journal-title":"Mol Neurobiol"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuropharm.2015.09.019","volume":"104","author":"E Beamer","year":"2016","unstructured":"Beamer E, G\u00f6l\u00f6ncs\u00e9r F, Horv\u00e1th G, Bek\u0151 K, Otrokocsi L, Kov\u00e1nyi B et al (2016) Purinergic mechanisms in neuroinflammation: an update from molecules to behavior. Neuropharmacology 104:94\u2013104","journal-title":"Neuropharmacology"},{"issue":"2","key":"9_CR6","doi-asserted-by":"publisher","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","volume":"316","author":"C Yang","year":"2019","unstructured":"Yang C, Hawkins KE, Dor\u00e9 S, Candelario-Jalil E (2019) Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol-Cell Physiol 316(2):C135\u2013C153","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"2","key":"9_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/14787210.2020.1812384","volume":"19","author":"SC Tauber","year":"2021","unstructured":"Tauber SC, Djukic M, Gossner J, Eiffert H, Br\u00fcck W, Nau R (2021) Sepsis-associated encephalopathy and septic encephalitis: an update. Expert Rev Anti-infe 19(2):215\u2013231","journal-title":"Expert Rev Anti-infe"},{"issue":"9","key":"9_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1139\/y11-065","volume":"89","author":"JG Kim","year":"2011","unstructured":"Kim JG, Sung HJ, Ok SH, Kwon SC, Cheon KS, Kim HJ et al (2011) Calcium sensitization involved in dexmedetomidine-induced contraction of isolated rat aorta. Can J Physiol Pharm 89(9):681\u2013689","journal-title":"Can J Physiol Pharm"},{"issue":"1","key":"9_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/(SICI)1096-9861(19960812)372:1<111::AID-CNE8>3.0.CO;2-6","volume":"372","author":"EM Talley","year":"1996","unstructured":"Talley EM, Rosin DL, Lee A, Guyenet PG, Lynch KR (1996) Distribution of \u03b12A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol 372(1):111\u2013134","journal-title":"J Comp Neurol"},{"issue":"1","key":"9_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/(SICI)1096-9861(19960812)372:1<135::AID-CNE9>3.0.CO;2-4","volume":"372","author":"DL Rosin","year":"1996","unstructured":"Rosin DL, Talley EM, Lee A, Stornetta RL, Gaylinn BD, Guyenet PG et al (1996) Distribution of \u03b12C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol 372(1):135\u2013165","journal-title":"J Comp Neurol"},{"issue":"6","key":"9_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0165-6147(97)01063-8","volume":"18","author":"E MacDonald","year":"1997","unstructured":"MacDonald E, Kobilka BK, Scheinin M (1997) Gene targeting\u2014homing in on \u03b12-adrenoceptor-subtype function. Trends Pharmacol Sci 18(6):211\u2013219","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"9_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","volume":"160","author":"J Scholz","year":"2019","unstructured":"Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI et al (2019) The IASP classification of chronic pain for ICD-11. Pain 160(1):53\u201359","journal-title":"Pain"},{"issue":"7","key":"9_CR13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/sj.bjp.0701520","volume":"122","author":"JC Hunter","year":"1997","unstructured":"Hunter JC, Fontana DJ, Hedley LR, Jasper JR, Lewis R, Link RE et al (1997) Assessment of the role of \u03b12-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Brit J Pharmacol 122(7):1339\u20131344","journal-title":"Brit J Pharmacol"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-540-79090-7_1","volume":"194","author":"R Baron","year":"2009","unstructured":"Baron R (2009) Sensory nerves. Handb Exp Pharmacol 194:3\u201330","journal-title":"Handb Exp Pharmacol"},{"key":"9_CR15","doi-asserted-by":"crossref","unstructured":"Maze M, Virtanen R, Daunt D, Banks SJM, Stover EP, Feldman D (1991) Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: in vivo and in vitro studies. Anesthesia Analgesia 73(2):204","DOI":"10.1213\/00000539-199108000-00015"},{"issue":"1","key":"9_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/08998280.2001.11927725","volume":"14","author":"R Gertler","year":"2001","unstructured":"Gertler R, Brown HC, Mitchell DH, Silvius EN (2001) Dexmedetomidine: a novel sedative-analgesic agent. Bayl Univ Medical Cent Proc 14(1):13\u201321","journal-title":"Bayl Univ Medical Cent Proc"},{"issue":"3\u20134","key":"9_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ando.2020.03.012","volume":"82","author":"J Motiejunaite","year":"2021","unstructured":"Motiejunaite J, Amar L, Vidal-Petiot E (2021) Adrenergic receptors and cardiovascular effects of catecholamines. Ann D\u2019endocrinologie 82(3\u20134):193\u2013197","journal-title":"Ann D\u2019endocrinologie"},{"issue":"5","key":"9_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrn2834","volume":"11","author":"C L\u00fcscher","year":"2010","unstructured":"L\u00fcscher C, Slesinger PA (2010) Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci 11(5):301\u2013315","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"9_CR19","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.bbamem.2012.10.004","volume":"1828","author":"GW Zamponi","year":"2013","unstructured":"Zamponi GW, Currie KPM (2013) Regulation of CaV2 calcium channels by G protein coupled receptors. Biochimica Et Biophysica Acta Bba - Biomembr 1828(7):1629\u20131643","journal-title":"Biochimica Et Biophysica Acta Bba - Biomembr"},{"issue":"31","key":"9_CR20","doi-asserted-by":"publisher","first-page":"19125","DOI":"10.1074\/jbc.272.31.19125","volume":"272","author":"GJD Rocca","year":"1997","unstructured":"Rocca GJD, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ (1997) Ras-dependent mitogen-activated protein kinase activation by g protein-coupled receptors convergence of Gi- and Gq-mediated pathways on calcium\/calmodulin, Pyk2, and Src kinase. J Biol Chem 272(31):19125\u201319132","journal-title":"J Biol Chem"},{"key":"9_CR21","doi-asserted-by":"crossref","unstructured":"Dorn GW, Oswald KJ, McCluskey TS, Kuhel DG, Liggett SB (1997) \u03b12A-Adrenergic receptor stimulated calcium release is transduced by Gi-associated G\u03b2\u03b3-mediated activation of phospholipase C. Biochemistry 36(21):6415\u20136423","DOI":"10.1021\/bi970080s"},{"issue":"26","key":"9_CR22","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1073\/pnas.96.26.14669","volume":"96","author":"JW Putney","year":"1999","unstructured":"Putney JW (1999) TRP, inositol 1,4,5-trisphosphate receptors, and capacitative calcium entry. Proc National Acad Sci 96(26):14669\u201314671","journal-title":"Proc National Acad Sci"},{"issue":"5","key":"9_CR23","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.01.016","volume":"28","author":"J Huang","year":"2019","unstructured":"Huang J, Jiang Q (2019) Dexmedetomidine protects against neurological dysfunction in a mouse intracerebral hemorrhage model by inhibiting mitochondrial dysfunction-derived oxidative stress. J Stroke Cerebrovasc Dis 28(5):1281\u20131289","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"Pt B","key":"9_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108332","volume":"101","author":"M Tian","year":"2021","unstructured":"Tian M, Wang W, Wang K, Jin P, Lenahan C, Wang Y et al (2021) Dexmedetomidine alleviates cognitive impairment by reducing blood-brain barrier interruption and neuroinflammation via regulating Th1\/Th2\/Th17 polarization in an experimental sepsis model of mice. Int Immunopharmacol 101(Pt B):108332","journal-title":"Int Immunopharmacol"},{"key":"9_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118980","volume":"270","author":"H Xue","year":"2021","unstructured":"Xue H, Wu Z, Xu Y, Gao Q, Zhang Y, Li C et al (2021) Dexmedetomidine post-conditioning ameliorates long-term neurological outcomes after neonatal hypoxic ischemia: the role of autophagy. Life Sci 270:118980","journal-title":"Life Sci"},{"key":"9_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.555532","volume":"11","author":"Y Gao","year":"2020","unstructured":"Gao Y, Zhang Y, Dong Y, Wu X, Liu H (2020) Dexmedetomidine mediates neuroglobin up-regulation and alleviates the hypoxia\/reoxygenation injury by inhibiting neuronal apoptosis in developing rats. Front Pharmacol 11:555532","journal-title":"Front Pharmacol"},{"issue":"11","key":"9_CR27","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.1007\/s12035-021-02512-9","volume":"58","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li L, Zhang J, Cui H, Wang J, Wang C et al (2021) Dexmedetomidine alleviates lipopolysaccharide-induced hippocampal neuronal apoptosis via inhibiting the p38 MAPK\/c-Myc\/CLIC4 signaling pathway in rats. Mol Neurobiol 58(11):5533\u20135547","journal-title":"Mol Neurobiol"},{"issue":"5","key":"9_CR28","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1007\/s12035-020-02223-7","volume":"58","author":"H Lv","year":"2021","unstructured":"Lv H, Li Y, Cheng Q, Chen J, Chen W (2021) Neuroprotective effects against cerebral ischemic injury exerted by dexmedetomidine via the HDAC5\/NPAS4\/MDM2\/PSD-95 axis. Mol Neurobiol 58(5):1990\u20132004","journal-title":"Mol Neurobiol"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.2147\/DDDT.S140644","volume":"11","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang X, Zhang B, He G, Zhou L, Xie Y (2017) Dexmedetomidine reduces the neuronal apoptosis related to cardiopulmonary bypass by inhibiting activation of the JAK2\u2013STAT3 pathway. Drug Des Dev Ther 11:2787\u20132799","journal-title":"Drug Des Dev Ther"},{"key":"9_CR30","doi-asserted-by":"crossref","unstructured":"Liu P, Chen T, Tan F, Tian J, Zheng L, Deng Y et al (2020) Dexmedetomidine alleviated neuropathic pain in dorsal root ganglion neurons by inhibition of anaerobic glycolysis activity and enhancement of ROS tolerance. Bioscience Rep 40(5):BSR20191994","DOI":"10.1042\/BSR20191994"},{"issue":"3","key":"9_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1248\/bpb.b19-00711","volume":"43","author":"L Qiu","year":"2020","unstructured":"Qiu L, Ge L, Hu Q (2020) Dexmedetomidine protects SK-N-SH nerve cells from oxidative injury by maintaining iron homeostasis. Biological Pharm Bulletin 43(3):424\u2013431","journal-title":"Biological Pharm Bulletin"},{"key":"9_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"1","key":"9_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. Bmc Med Res Methodol 5(1):13","journal-title":"Bmc Med Res Methodol"},{"key":"9_CR34","unstructured":"The Jackson Laboratory. Body weight information for C57BL\/6J. Available from: https:\/\/www.jax.org\/jax-mice-and-services\/strain-data-sheet-pages\/body-weight-chart-000664"},{"issue":"1","key":"9_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5625\/lar.2017.33.1.8","volume":"33","author":"HJ Shin","year":"2017","unstructured":"Shin HJ, Cho YM, Shin HJ, Kim HD, Choi KM, Kim MG et al (2017) Comparison of commonly used ICR stocks and the characterization of Korl:ICR. Laboratory Animal Res 33(1):8\u201314","journal-title":"Laboratory Animal Res"},{"key":"9_CR36","unstructured":"ENVIGO. CD-1 mice growth curve. Available from: https:\/\/www.envigo.com\/model\/hsd-icr-cd-1"},{"issue":"9","key":"9_CR37","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1080\/10934529.2012.672071","volume":"47","author":"F Nistiar","year":"2012","unstructured":"Nistiar F, Racz O, Lukacinova A, Hubkova B, Novakova J, Lovasova E et al (2012) Age dependency on some physiological and biochemical parameters of male wistar rats in controlled environment. J Environ Sci Heal Part 47(9):1224\u20131233","journal-title":"J Environ Sci Heal Part"},{"key":"9_CR38","unstructured":"Taconic. Sprague dawley rat model. Available from: https:\/\/www.taconic.com\/pdfs\/sprague-dawley-rat.pdf"},{"key":"9_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107795","volume":"96","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Tan SL, Du J, Chen Y, Jia J, Feng JG et al (2021) Dexmedetomidine alleviates neuroinflammation, restores sleep disorders and neurobehavioral abnormalities in rats with minimal hepatic encephalopathy. Int Immunopharmacol 96:107795","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"9_CR40","first-page":"3957","volume":"18","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhou W, Dong H, Ma X, He Z (2018) Dexmedetomidine pretreatment inhibits cerebral ischemia\/reperfusion-induced neuroinflammation via activation of AMPK. Mol Med Rep 18(4):3957\u20133964","journal-title":"Mol Med Rep"},{"issue":"6","key":"9_CR41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/19768354.2019.1688185","volume":"23","author":"L Hwang","year":"2019","unstructured":"Hwang L, Ko IG, Jin JJ, Kim SH, Kim CJ, Chang B et al (2019) Dexmedetomidine ameliorates memory impairment in sleep-deprived mice. Anim Cells Syst 23(6):371\u2013379","journal-title":"Anim Cells Syst"},{"issue":"1","key":"9_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12871-019-0808-5","volume":"19","author":"N Wang","year":"2019","unstructured":"Wang N, Wang M (2019) Dexmedetomidine suppresses sevoflurane anesthesia-induced neuroinflammation through activation of the PI3K\/Akt\/mTOR pathway. Bmc Anesthesiol 19(1):134","journal-title":"Bmc Anesthesiol"},{"issue":"4","key":"9_CR43","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s12640-021-00379-1","volume":"39","author":"S \u00c7\u0131nar","year":"2021","unstructured":"\u00c7\u0131nar S, T\u00fcmkaya L, Mercantepe T, Saral S, Rak\u0131c\u0131 S, Y\u0131lmaz A et al (2021) Can dexmedetomidine be effective in the protection of radiotherapy-induced brain damage in the rat? Neurotox Res 39(4):1338\u20131351","journal-title":"Neurotox Res"},{"key":"9_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.146682","volume":"1732","author":"D Sun","year":"2020","unstructured":"Sun D, Wang J, Liu X, Fan Y, Yang M, Zhang J (2020) Dexmedetomidine attenuates endoplasmic reticulum stress-induced apoptosis and improves neuronal function after traumatic brain injury in mice. Brain Res 1732:146682","journal-title":"Brain Res"},{"key":"9_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104493","volume":"129","author":"KM Chiu","year":"2019","unstructured":"Chiu KM, Lin TY, Lee MY, Lu CW, Wang MJ, Wang SJ (2019) Dexmedetomidine protects neurons from kainic acid-induced excitotoxicity by activating BDNF signaling. Neurochem Int 129:104493","journal-title":"Neurochem Int"},{"issue":"5","key":"9_CR46","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3892\/ijmm.2013.1301","volume":"31","author":"L Hwang","year":"2013","unstructured":"Hwang L, Choi IY, Kim SE, Ko IG, Shin MS, Kim CJ et al (2013) Dexmedetomidine ameliorates intracerebral hemorrhage-induced memory impairment by inhibiting apoptosis and enhancing brain-derived neurotrophic factor expression in the rat hippocampus. Int J Mol Med 31(5):1047\u20131056","journal-title":"Int J Mol Med"},{"issue":"4","key":"9_CR47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/01616412.2017.1281197","volume":"39","author":"Q Ning","year":"2017","unstructured":"Ning Q, Liu Z, Wang X, Zhang R, Zhang J, Yang M et al (2017) Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice. Neurol Res 39(4):357\u2013366","journal-title":"Neurol Res"},{"issue":"6","key":"9_CR48","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jocn.2009.10.012","volume":"17","author":"H Ayoglu","year":"2010","unstructured":"Ayoglu H, Gul S, Hanci V, Bahadir B, Bektas S, Mungan AG et al (2010) The effects of dexmedetomidine dosage on cerebral vasospasm in a rat subarachnoid haemorrhage model. J Clin Neurosci 17(6):770\u2013773","journal-title":"J Clin Neurosci"},{"issue":"4","key":"9_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. \u00c9vid Based Ment Heal 22(4):153","journal-title":"\u00c9vid Based Ment Heal"},{"key":"9_CR50","unstructured":"Harrer M, Cuijpers P, Furukawa T, Ebert DD, Dmetar: companion R package for the guide \u201cdoing meta-analysis in R\u201d. Available from: http:\/\/dmetar.protectlab.org\/"},{"key":"9_CR51","doi-asserted-by":"crossref","unstructured":"Fodor LA, Cote\u021b CD, Cuijpers P, Szamoskozi \u0218tefan, David D, Cristea IA (2018) The effectiveness of virtual reality based interventions for symptoms of anxiety and depression: a meta-analysis. Sci Rep 8(1):10323","DOI":"10.1038\/s41598-018-28113-6"},{"issue":"10","key":"9_CR52","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","volume":"61","author":"JL Peters","year":"2008","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008) Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61(10):991\u2013996","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"9_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. Bmc Med Res Methodol 14(1):43","journal-title":"Bmc Med Res Methodol"},{"key":"9_CR54","doi-asserted-by":"crossref","unstructured":"Du Sert NP, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ et al (2020) Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. Plos Biol 18(7):e3000411","DOI":"10.1371\/journal.pbio.3000411"},{"key":"9_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2016.04.074","volume":"1644","author":"YJ Zhu","year":"2016","unstructured":"Zhu YJ, Peng K, Meng XW, Ji FH (2016) Attenuation of neuroinflammation by dexmedetomidine is associated with activation of a cholinergic anti-inflammatory pathway in a rat tibial fracture model. Brain Res 1644:1\u20138","journal-title":"Brain Res"},{"issue":"3","key":"9_CR56","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3892\/mmr.2021.12300","volume":"24","author":"X Feng","year":"2021","unstructured":"Feng X, Ma W, Zhu J, Jiao W, Wang Y (2021) Dexmedetomidine alleviates early brain injury following traumatic brain injury by inhibiting autophagy and neuroinflammation through the ROS\/Nrf2 signaling pathway. Mol Med Rep 24(3):661","journal-title":"Mol Med Rep"},{"issue":"4","key":"9_CR57","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1213\/ANE.0000000000005699","volume":"134","author":"N Kii","year":"2022","unstructured":"Kii N, Sawada A, Yoshikawa Y, Tachibana S, Yamakage M (2022) Dexmedetomidine ameliorates perioperative neurocognitive disorders by suppressing monocyte-derived macrophages in mice with preexisting traumatic brain injury. Anesthesia Analgesia 134(4):869\u2013880","journal-title":"Anesthesia Analgesia"},{"issue":"10","key":"9_CR58","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1007\/s12035-021-02417-7","volume":"58","author":"YL Wang","year":"2021","unstructured":"Wang YL, Zhang Y, Cai DS (2021) Dexmedetomidine ameliorates postoperative cognitive dysfunction via the MicroRNA-381-mediated EGR1\/p53 axis. Mol Neurobiol 58(10):5052\u20135066","journal-title":"Mol Neurobiol"},{"issue":"9","key":"9_CR59","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/acn3.50878","volume":"6","author":"F Li","year":"2019","unstructured":"Li F, Wang X, Zhang Z, Zhang X, Gao P (2019) Dexmedetomidine attenuates neuroinflammatory-induced apoptosis after traumatic brain injury via Nrf2 signaling pathway. Ann Clin Transl Neur 6(9):1825\u20131835","journal-title":"Ann Clin Transl Neur"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbi.2020.10.008","volume":"91","author":"B Mei","year":"2021","unstructured":"Mei B, Li J, Zuo Z (2021) Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central \u03b12A adrenoceptor. Brain Behav Immun 91:296\u2013314","journal-title":"Brain Behav Immun"},{"issue":"5","key":"9_CR61","doi-asserted-by":"publisher","first-page":"819","DOI":"10.4103\/1673-5374.232529","volume":"13","author":"D Wang","year":"2018","unstructured":"Wang D, Xu X, Wu YG, Lyu L, Zhou ZW, Zhang JN (2018) Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms. Neural Regen Res 13(5):819\u2013826","journal-title":"Neural Regen Res"},{"issue":"2","key":"9_CR62","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/ALN.0000000000003390","volume":"133","author":"R Li","year":"2020","unstructured":"Li R, Lai IK, Pan JZ, Zhang P, Maze M (2020) Dexmedetomidine exerts an anti-inflammatory effect via \u03b12 adrenoceptors to prevent lipopolysaccharide-induced cognitive decline in mice. Anesthesiology 133(2):393\u2013407","journal-title":"Anesthesiology"},{"issue":"3","key":"9_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41419-019-1416-5","volume":"10","author":"YB Sun","year":"2019","unstructured":"Sun YB, Zhao H, Mu DL, Zhang W, Cui J, Wu L et al (2019) Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Cell Death Dis 10(3):167","journal-title":"Cell Death Dis"},{"key":"9_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.646265","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Xiao F, Zhang J, Wang X, Ying J, Wei G et al (2021) Dexmedetomidine mitigated NLRP3-mediated neuroinflammation via the ubiquitin-autophagy pathway to improve perioperative neurocognitive disorder in mice. Front Pharmacol 12:646265","journal-title":"Front Pharmacol"},{"issue":"5","key":"9_CR65","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/ALN.0000000000002038","volume":"128","author":"J Hu","year":"2018","unstructured":"Hu J, Vacas S, Feng X, Lutrin D, Uchida Y, Lai IK et al (2018) Dexmedetomidine prevents cognitive decline by enhancing resolution of high mobility group box 1 protein\u2013induced inflammation through a vagomimetic action in mice. Anesthesiology 128(5):921\u2013931","journal-title":"Anesthesiology"},{"issue":"1","key":"9_CR66","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbrc.2017.10.124","volume":"495","author":"KL Xu","year":"2018","unstructured":"Xu KL, Liu XQ, Yao YL, Ye MR, Han YG, Zhang T et al (2018) Effect of dexmedetomidine on rats with convulsive status epilepticus and association with activation of cholinergic anti-inflammatory pathway. Biochem Bioph Res Commun 495(1):421\u2013426","journal-title":"Biochem Bioph Res Commun"},{"issue":"1","key":"9_CR67","doi-asserted-by":"publisher","first-page":"7920","DOI":"10.1080\/21655979.2021.1981757","volume":"12","author":"B Guo","year":"2021","unstructured":"Guo B, Chen C, Yang L, Zhu R (2021) Effects of dexmedetomidine on postoperative cognitive function of sleep deprivation rats based on changes in inflammatory response. Bioengineered 12(1):7920\u20137928","journal-title":"Bioengineered"},{"issue":"1","key":"9_CR68","first-page":"415","volume":"18","author":"WG Wang","year":"2018","unstructured":"Wang WG, Wang L, Jiao ZH, Xue B, Xu ZW (2018) Locomotor activity of rats with SCI is improved by dexmedetomidine by targeting the expression of inflammatory factors. Mol Med Rep 18(1):415\u2013420","journal-title":"Mol Med Rep"},{"issue":"1","key":"9_CR69","doi-asserted-by":"publisher","first-page":"13345","DOI":"10.1038\/s41598-021-92906-5","volume":"11","author":"P Li","year":"2021","unstructured":"Li P, Shen T, Luo X, Yang J, Luo Z, Tan Y et al (2021) Modulation of microglial phenotypes by dexmedetomidine through TREM2 reduces neuroinflammation in heatstroke. Sci Rep 11(1):13345","journal-title":"Sci Rep"},{"key":"9_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116553","volume":"235","author":"L Chen","year":"2019","unstructured":"Chen L, Cao J, Cao D, Wang M, Xiang H, Yang Y et al (2019) Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia\/reperfusion injury: an in vivo and in vitro study. Life Sci 235:116553","journal-title":"Life Sci"},{"issue":"3","key":"9_CR71","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s12028-021-01381-3","volume":"36","author":"D Karakaya","year":"2022","unstructured":"Karakaya D, Cakir-Aktas C, Uzun S, Soylemezoglu F, Mut M (2022) Tailored therapeutic doses of dexmedetomidine in evolving neuroinflammation after traumatic brain injury. Neurocrit Care 36(3):802\u2013814","journal-title":"Neurocrit Care"},{"issue":"9","key":"9_CR72","doi-asserted-by":"publisher","first-page":"b17","DOI":"10.1248\/bpb.b17-00224","volume":"40","author":"Y Lu","year":"2017","unstructured":"Lu Y, Lin B, Zhong J (2017) The therapeutic effect of dexmedetomidine on rat diabetic neuropathy pain and the mechanism. Biological Pharm Bulletin 40(9):b17-00224","journal-title":"Biological Pharm Bulletin"},{"issue":"9","key":"9_CR73","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1113\/EP088596","volume":"105","author":"W Zhang","year":"2020","unstructured":"Zhang W, Yu T, Cui X, Yu H, Li X (2020) Analgesic effect of dexmedetomidine in rats after chronic constriction injury by mediating microRNA-101 expression and the E2F2\u2013TLR4\u2013NF-\u03baB axis. Exp Physiol 105(9):1588\u20131597","journal-title":"Exp Physiol"},{"key":"9_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114743","volume":"382","author":"A Minaei","year":"2019","unstructured":"Minaei A, Haghdoost-Yazdi H (2019) Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of KATP channels, alpha 2 adrenoceptors and anti-inflammatory mechanisms. Toxicol Appl Pharm 382:114743","journal-title":"Toxicol Appl Pharm"},{"issue":"5","key":"9_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196897","volume":"13","author":"X Zhang","year":"2018","unstructured":"Zhang X, Yan F, Feng J, Qian H, Cheng Z, Yang Q et al (2018) Dexmedetomidine inhibits inflammatory reaction in the hippocampus of septic rats by suppressing NF-\u03baB pathway. PLoS ONE 13(5):e0196897","journal-title":"PLoS ONE"},{"issue":"4","key":"9_CR76","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3892\/etm.2021.10479","volume":"22","author":"W Shan","year":"2021","unstructured":"Shan W, Liao X, Tang Y, Liu J (2021) Dexmedetomidine alleviates inflammation in neuropathic pain by suppressing NLRP3 via Nrf2 activation. Exp Ther Med 22(4):1046","journal-title":"Exp Ther Med"},{"key":"9_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuro.2018.09.004","volume":"69","author":"H Xu","year":"2018","unstructured":"Xu H, Zhao B, She Y, Song X (2018) Dexmedetomidine ameliorates lidocaine-induced spinal neurotoxicity via inhibiting glutamate release and the PKC pathway. Neurotoxicology 69:77\u201383","journal-title":"Neurotoxicology"},{"issue":"12","key":"9_CR78","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1111\/jcmm.14688","volume":"23","author":"L Zhao","year":"2019","unstructured":"Zhao L, Zhai M, Yang X, Guo H, Cao Y, Wang D et al (2019) Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia-reperfusion injury by targeting the CNPY2-endoplasmic reticulum stress signalling. J Cell Mol Med 23(12):8173\u20138183","journal-title":"J Cell Mol Med"},{"key":"9_CR79","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2017.04.011","volume":"649","author":"E Kim","year":"2017","unstructured":"Kim E, Kim HC, Lee S, Ryu HG, Park YH, Kim JH et al (2017) Dexmedetomidine confers neuroprotection against transient global cerebral ischemia\/reperfusion injury in rats by inhibiting inflammation through inactivation of the TLR-4\/NF-\u03baB pathway. Neurosci Lett 649:20\u201327","journal-title":"Neurosci Lett"},{"key":"9_CR80","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.biopha.2017.08.125","volume":"95","author":"M Shen","year":"2017","unstructured":"Shen M, Wang S, Wen X, Han XR, Wang YJ, Zhou XM et al (2017) Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K\/Akt\/mTOR signaling pathway in rats with traumatic brain injury. Biomed Pharmacother 95:885\u2013893","journal-title":"Biomed Pharmacother"},{"key":"9_CR81","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.biopha.2017.06.051","volume":"93","author":"SL Wang","year":"2017","unstructured":"Wang SL, Duan L, Xia B, Liu Z, Wang Y, Wang GM (2017) Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4\/NF-\u03baB pathways model of cerebral ischemia reperfusion. Biomed Pharmacother 93:1337\u20131342","journal-title":"Biomed Pharmacother"},{"key":"9_CR82","doi-asserted-by":"crossref","unstructured":"Kan MC, Wang WP, Yao GD, Li JT, Xie T, Wang W et al (2013) Anticonvulsant effect of dexmedetomidine in a rat model of self-sustaining status epilepticus with prolonged amygdala stimulation. Neurosci Lett 543:17\u201321","DOI":"10.1016\/j.neulet.2013.03.036"},{"issue":"2","key":"9_CR83","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11011-016-9945-4","volume":"32","author":"F Yuan","year":"2017","unstructured":"Yuan F, Fu H, Sun K, Wu S, Dong T (2017) Effect of dexmedetomidine on cerebral ischemia-reperfusion rats by activating mitochondrial ATP-sensitive potassium channel. Metab Brain Dis 32(2):539\u2013546","journal-title":"Metab Brain Dis"},{"issue":"1","key":"9_CR84","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12871-022-01658-w","volume":"22","author":"M Li","year":"2022","unstructured":"Li M, Jin Z, Zhan J, Wang Y, Chen K (2022) Dexmedetomidine improved one-lung ventilation-induced cognitive dysfunction in rats. Bmc Anesthesiol 22(1):115","journal-title":"Bmc Anesthesiol"},{"issue":"2","key":"9_CR85","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11064-021-03461-4","volume":"47","author":"S Zhao","year":"2022","unstructured":"Zhao S, Cheng WJ, Liu X, Li Z, Li HZ, Shi N et al (2022) Effects of dexmedetomidine and oxycodone on neurocognitive and inflammatory response after tourniquet-induced ischemia-reperfusion injury. Neurochem Res 47(2):461\u2013469","journal-title":"Neurochem Res"},{"key":"9_CR86","doi-asserted-by":"crossref","unstructured":"Deng F, Cai L, Zhou B, Zhou Z, Xu G (2020) Whole transcriptome sequencing reveals dexmedetomidine-improves postoperative cognitive dysfunction in rats via modulating lncRNA. 3 Biotech 10(5):202","DOI":"10.1007\/s13205-020-02190-9"},{"issue":"7","key":"9_CR87","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/brainsci11070846","volume":"11","author":"Z Liaquat","year":"2021","unstructured":"Liaquat Z, Xu X, Zilundu PLM, Fu R, Zhou L (2021) The current role of dexmedetomidine as neuroprotective agent: an updated review. Brain Sci 11(7):846","journal-title":"Brain Sci"},{"issue":"2","key":"9_CR88","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/pan.13553","volume":"29","author":"CE Hoorn","year":"2019","unstructured":"Hoorn CE, Hoeks SE, Essink H, Tibboel D, Graaff JC (2019) A systematic review and narrative synthesis on the histological and neurobehavioral long-term effects of dexmedetomidine. Pediatr Anesth 29(2):125\u2013136","journal-title":"Pediatr Anesth"},{"key":"9_CR89","doi-asserted-by":"crossref","unstructured":"Zhai Y, Zhu Y, Liu J, Xie K, Yu J, Yu L et al (2020) Dexmedetomidine post-conditioning alleviates cerebral ischemia-reperfusion injury in rats by inhibiting high mobility group protein B1 group (HMGB1)\/toll-like receptor 4 (TLR4)\/nuclear factor kappa B (NF-\u03baB) signaling pathway. Med Sci Monit Int Medical J Exp Clin Res 26:e918617-1\u2013e918617-11","DOI":"10.12659\/MSM.918617"},{"issue":"8","key":"9_CR90","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/medicina58080993","volume":"58","author":"KS Alharbi","year":"2022","unstructured":"Alharbi KS, Afzal M, Alzarea SI, Khan SA, Alomar FA, Kazmi I (2022) Rosinidin protects streptozotocin-induced memory impairment-activated neurotoxicity by suppressing oxidative stress and inflammatory mediators in rats. Medicina 58(8):993","journal-title":"Medicina"},{"issue":"6","key":"9_CR91","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/ars.2015.6419","volume":"26","author":"K Johansson","year":"2017","unstructured":"Johansson K, Cebula M, Rengby O, Dreij K, Carlstr\u00f6m KE, Sigmundsson K et al (2017) Cross talk in HEK293 cells between Nrf2, HIF, and NF-\u03baB activities upon challenges with redox therapeutics characterized with single-cell resolution. Antioxid Redox Sign 26(6):229\u2013246","journal-title":"Antioxid Redox Sign"},{"issue":"1","key":"9_CR92","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1038\/ncomms11624","volume":"7","author":"EH Kobayashi","year":"2016","unstructured":"Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H et al (2016) Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun 7(1):11624","journal-title":"Nat Commun"},{"issue":"6","key":"9_CR93","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","volume":"34","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Motohashi H, Yamamoto M (2013) Toward clinical application of the Keap1\u2013Nrf2 pathway. Trends Pharmacol Sci 34(6):340\u2013346","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"9_CR94","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00011-021-01515-5","volume":"71","author":"N Wang","year":"2022","unstructured":"Wang N, Nie H, Zhang Y, Han H, Wang S, Liu W et al (2022) Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2\/HO-1\/NLRP3 pathway. Inflamm Res 71(1):93\u2013106","journal-title":"Inflamm Res"},{"issue":"13","key":"9_CR95","first-page":"4574","volume":"26","author":"G Shao","year":"2022","unstructured":"Shao G (2022) Dexmedetomidine inhibits cerebral nerve cell apoptosis after cerebral hemorrhage in rats via the Nrf2\/HO-1\/NQO1 signaling pathway. Eur Rev Med Pharmaco 26(13):4574\u20134582","journal-title":"Eur Rev Med Pharmaco"},{"key":"9_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.147141","volume":"1750","author":"P Feng","year":"2021","unstructured":"Feng P, Zhang A, Su M, Cai H, Wang X, Zhang Y (2021) Dexmedetomidine inhibits apoptosis of astrocytes induced by oxygen-glucose deprivation via targeting JAK\/STAT3 signal pathway. Brain Res 1750:147141","journal-title":"Brain Res"},{"key":"9_CR97","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2022e12145","volume":"55","author":"H Liu","year":"2022","unstructured":"Liu H, Li J, Jiang L, He J, Zhang H, Wang K (2022) Dexmedetomidine pretreatment alleviates cerebral ischemia\/reperfusion injury by inhibiting neuroinflammation through the JAK2\/STAT3 pathway. Braz J Med Biol Res 55:e12145","journal-title":"Braz J Med Biol Res"},{"key":"9_CR98","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.etap.2017.03.017","volume":"52","author":"J Lv","year":"2017","unstructured":"Lv J, Wei Y, Chen Y, Zhang X, Gong Z, Jiang Y et al (2017) Dexmedetomidine attenuates propofol-induce neuroapoptosis partly via the activation of the PI3k\/Akt\/GSK3\u03b2 pathway in the hippocampus of neonatal rats. Environ Toxicol Phar 52:121\u2013128","journal-title":"Environ Toxicol Phar"},{"key":"9_CR99","doi-asserted-by":"publisher","first-page":"3071959","DOI":"10.1155\/2018\/3071959","volume":"2018","author":"X Cheng","year":"2018","unstructured":"Cheng X, Hu J, Wang Y, Ye H, Li X, Gao Q et al (2018) Effects of dexmedetomidine postconditioning on myocardial ischemia\/reperfusion injury in diabetic rats: role of the PI3K\/Akt-dependent signaling pathway. J Diabetes Res 2018:3071959","journal-title":"J Diabetes Res"},{"key":"9_CR100","first-page":"4293900","volume":"2021","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhang H, Zhao L, Zhao Z, Liu Y (2021) Effect and mechanism of lidocaine pretreatment combined with dexmedetomidine on oxidative stress in patients with intracranial aneurysm clipping. J Healthc Eng 2021:4293900","journal-title":"J Healthc Eng"},{"issue":"4","key":"9_CR101","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1267\/ahc.21-00040","volume":"54","author":"X Sun","year":"2021","unstructured":"Sun X, Kang F, Shen Y, Shen Y, Li J (2021) Dexmedetomidine and phosphocreatine post-treatment provides protection against focal cerebral ischemia-reperfusion injury in rats. Acta Histochem Cytoc 54(4):105\u2013113","journal-title":"Acta Histochem Cytoc"},{"key":"9_CR102","first-page":"63","volume":"7","author":"A Garthe","year":"2013","unstructured":"Garthe A, Kempermann G (2013) An old test for new neurons: refining the Morris water maze to study the functional relevance of adult hippocampal neurogenesis. Front Neurosci-switz 7:63","journal-title":"Front Neurosci-switz"},{"key":"9_CR103","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ebiom.2018.10.021","volume":"37","author":"A Alam","year":"2018","unstructured":"Alam A, Hana Z, Jin Z, Suen KC, Ma D (2018) Surgery, neuroinflammation and cognitive impairment. EBioMedicine 37:547\u2013556","journal-title":"EBioMedicine"},{"issue":"9","key":"9_CR104","first-page":"1071","volume":"38","author":"S Fang","year":"2018","unstructured":"Fang S, Chen Y, Yao P, Li Y, Yang Y, Xu G (2018) Dexmedetomidine alleviates postoperative cognitive dysfunction in aged rats probably via silent information regulator 1 pathway. Nan Fang Yi Ke Da Xue Xue Bao J South Medical Univ 38(9):1071\u20131075","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao J South Medical Univ"},{"issue":"15","key":"9_CR105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2116844119","volume":"119","author":"B Lei","year":"2022","unstructured":"Lei B, Lv L, Hu S, Tang Y, Zhong Y (2022) Social experiences switch states of memory engrams through regulating hippocampal Rac1 activity. Proc National Acad Sci 119(15):e2116844119","journal-title":"Proc National Acad Sci"},{"issue":"1","key":"9_CR106","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1038\/s41467-019-13236-9","volume":"10","author":"L Lv","year":"2019","unstructured":"Lv L, Liu Y, Xie J, Wu Y, Zhao J, Li Q et al (2019) Interplay between \u03b12-chimaerin and Rac1 activity determines dynamic maintenance of long-term memory. Nat Commun 10(1):5313","journal-title":"Nat Commun"},{"issue":"2","key":"9_CR107","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.celrep.2018.09.033","volume":"25","author":"Y Liu","year":"2018","unstructured":"Liu Y, Lv L, Wang L, Zhong Y (2018) Social isolation induces Rac1-dependent forgetting of social memory. Cell Rep 25(2):288-295.e3","journal-title":"Cell Rep"},{"issue":"3","key":"9_CR108","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.neuron.2017.05.039","volume":"95","author":"RL Davis","year":"2017","unstructured":"Davis RL, Zhong Y (2017) The biology of forgetting\u2014a perspective. Neuron 95(3):490\u2013503","journal-title":"Neuron"},{"issue":"4","key":"9_CR109","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.mcn.2009.04.005","volume":"41","author":"U Haditsch","year":"2009","unstructured":"Haditsch U, Leone DP, Farinelli M, Chrostek-Grashoff A, Brakebusch C, Mansuy IM et al (2009) A central role for the small GTPase Rac1 in hippocampal plasticity and spatial learning and memory. Mol Cell Neurosci 41(4):409\u2013419","journal-title":"Mol Cell Neurosci"},{"key":"9_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.914491","volume":"14","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zablah YB, Zhang H, Liu A, Gugustea R, Lee D et al (2022) Inhibition of Rac1 in ventral hippocampal excitatory neurons improves social recognition memory and synaptic plasticity. Front Aging Neurosci. 14:914491","journal-title":"Front Aging Neurosci."},{"issue":"5","key":"9_CR111","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrn3729","volume":"15","author":"ET Coffey","year":"2014","unstructured":"Coffey ET (2014) Nuclear and cytosolic JNK signalling in neurons. Nat Rev Neurosci 15(5):285\u2013299","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"9_CR112","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0896-6273(03)00645-7","volume":"40","author":"G Krapivinsky","year":"2003","unstructured":"Krapivinsky G, Krapivinsky L, Manasian Y, Ivanov A, Tyzio R, Pellegrino C et al (2003) The NMDA receptor Is coupled to the ERK pathway by a direct Interaction between NR2B and RasGRF1. Neuron 40(4):775\u2013784","journal-title":"Neuron"},{"issue":"5","key":"9_CR113","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1523\/JNEUROSCI.4086-04.2005","volume":"25","author":"JM Schmitt","year":"2005","unstructured":"Schmitt JM, Guire ES, Saneyoshi T, Soderling TR (2005) Calmodulin-Dependent kinase kinase\/calmodulin kinase I activity gates extracellular-regulated kinase-dependent long-term potentiation. J Neurosci 25(5):1281\u20131290","journal-title":"J Neurosci"},{"issue":"11","key":"9_CR114","doi-asserted-by":"publisher","first-page":"e2449","DOI":"10.1038\/cddis.2016.329","volume":"7","author":"XY Sun","year":"2016","unstructured":"Sun XY, Tuo QZ, Liuyang ZY, Xie AJ, Feng XL, Yan X et al (2016) Extrasynaptic NMDA receptor-induced tau overexpression mediates neuronal death through suppressing survival signaling ERK phosphorylation. Cell Death Dis 7(11):e2449\u2013e2449","journal-title":"Cell Death Dis"},{"issue":"8","key":"9_CR115","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.0511065103","volume":"103","author":"G Amadoro","year":"2006","unstructured":"Amadoro G, Ciotti MT, Costanzi M, Cestari V, Calissano P, Canu N (2006) NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation. Proc National Acad Sci 103(8):2892\u20132897","journal-title":"Proc National Acad Sci"},{"issue":"1","key":"9_CR116","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1385\/NMM:6:1:053","volume":"6","author":"CW Xie","year":"2004","unstructured":"Xie CW (2004) Calcium-regulated signaling pathways. Neuromol Med 6(1):53\u201364","journal-title":"Neuromol Med"},{"key":"9_CR117","unstructured":"Banerjee M, Shenoy RR (2021) Emphasizing roles of BDNF promoters and inducers in Alzheimer\u2019s disease for improving impaired cognition and memory. J Basic Clin Physiol Pharmacol 0(0):000010151520210182"},{"issue":"6","key":"9_CR118","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s10753-019-01082-2","volume":"42","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Li S, Liu J, Wen Q, Yu J, Yu L et al (2019) Role of JNK signaling pathway in dexmedetomidine post-conditioning-induced reduction of the inflammatory response and autophagy effect of focal cerebral ischemia reperfusion injury in rats. Inflammation 42(6):2181\u20132191","journal-title":"Inflammation"},{"issue":"3","key":"9_CR119","doi-asserted-by":"publisher","first-page":"271","DOI":"10.21307\/ane-2021-025","volume":"81","author":"G Li","year":"2021","unstructured":"Li G, Cao F, Jin Y, Wang Y, Wang D, Zhou L (2021) Role of NR2B\/ERK signaling in the neuroprotective effect of dexmedetomidine against sevoflurane induced neurological dysfunction in the developing rat brain. Acta Neurobiol Exp 81(3):271\u2013278","journal-title":"Acta Neurobiol Exp"},{"key":"9_CR120","doi-asserted-by":"publisher","first-page":"5458061","DOI":"10.1155\/2020\/5458061","volume":"2020","author":"Y Dong","year":"2020","unstructured":"Dong Y, Hong W, Tang Z, Gao Y, Wu X, Liu H (2020) Dexmedetomidine attenuates neurotoxicity in developing rats induced by sevoflurane through upregulating BDNF-TrkB-CREB and downregulating ProBDNF-P75NRT-RhoA signaling pathway. Mediat Inflamm 2020:5458061","journal-title":"Mediat Inflamm"}],"container-title":["Advances in Experimental Medicine and Biology","Advances in Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-26163-3_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:06:35Z","timestamp":1682323595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-26163-3_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031261626","9783031261633"],"references-count":120,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-26163-3_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"25 April 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}